Lilly Adds Two More Humalog Authorized Generics As Insurance Deductibles Reset

With rebate reform efforts stalled, insulin manufacturer broadens efforts to lower prices through authorized generics, but PBMs may still like the big rebates they can get on the original brands.

Diabetes

More from Drug Pricing

More from Scrip